AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇹🇳
RIVASTIGMINE in Tunisia
16 products registered with DPM — 0 active, 16 expired
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| VITACHOLINE 3 Gélule / 3 mg | 9373176H | TAHA PHARMA | expired | 17 Jun 2019 |
| VITACHOLINE 1.5 Gélule / 1.5 mg | 9373175H | TAHA PHARMA | expired | 17 Jun 2019 |
| VITACHOLINE 4.5 Gélule / 4.5 mg | 9373177H | TAHA PHARMA | expired | 17 Jun 2019 |
| VITACHOLINE 6 Gélule / 6 mg | 9373178H | TAHA PHARMA | expired | 17 Jun 2019 |
| RIVETAL Gélule / 6 mg | 7573094H | GENEPHARM S.A | expired | 28 Jun 2017 |
| RIVETAL Gélule / 1.5 mg | 7573091H | GENEPHARM S.A | expired | 16 Mar 2017 |
| RIVETAL Gélule / 4.5 mg | 7573093H | GENEPHARM S.A | expired | 16 Mar 2017 |
| RIVETAL Gélule / 3 mg | 7573092H | GENEPHARM S.A | expired | 16 Mar 2017 |
| VITACHOLINE 1.5 Gélule / 1.5 mg | 9373171H | TAHA PHARMA | expired | 21 Feb 2017 |
| RIVAXEL Solution buvable / 2 mg/ml | 9044291 | ADWYA | expired | 21 Feb 2017 |
| VITACHOLINE 3 Gélule / 3 mg | 9373172H | TAHA PHARMA | expired | 21 Feb 2017 |
| VITACHOLINE 4.5 Gélule / 4.5 mg | 9373173H | TAHA PHARMA | expired | 21 Feb 2017 |
| VITACHOLINE 6 Gélule / 6 mg | 9373174H | TAHA PHARMA | expired | 21 Feb 2017 |
| EXELON PATCH 5 Dispositif trans-dermique / 4.6 mg/24 H | 10283224H | NOVARTIS PHARMA SCHWEIZ AG | expired | 24 Jun 2011 |
| EXELON PATCH 10 Dispositif trans-dermique / 9.5 mg/24 H | 10283225H | NOVARTIS PHARMA SCHWEIZ AG | expired | 24 Jun 2011 |
| EXELON PATCH 10 Dispositif trans-dermique / 9.5 mg/24 H | 10283221H | NOVARTIS PHARMA SCHWEIZ AG | expired | 24 Jun 2011 |
RIVASTIGMINE — DPM Registration Details
DPM (Tunisia) has 16 registered products containing RIVASTIGMINE, of which 0 are currently active. Data is sourced directly from the official DPM drug register and refreshed daily.
Track RIVASTIGMINE registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.